SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-00-011630
Filing Date
2000-12-19
Accepted
2000-12-19 00:00:00
Documents
5
Period of Report
2000-09-30

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS INC. y43604e10-k.txt 10-K 281980
2 EMPLOYMENT AGREEMENT y43604ex10-42.txt EX-10.42 34624
3 SUBSIDIARIES y43604ex21.txt EX-21 530
4 CONSENT OF KPMG LLP y43604ex23.txt EX-23 1053
5 FINANCIAL DATA SCHEDULE y43604ex27.txt EX-27 2134
  Complete submission text file 0000950123-00-011630.txt   322368
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 791430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances